SeeVay is a baby product store that provides comprehensive safety checklists and a curated selection of high-quality, safe baby products. Our mission is to give new moms peace of mind by ensuring their baby’s safety is always top of mind.
SPOTLIGHT –
Sema4|GeneDx has announced its partnership in the GUARDIAN study, a collaboration for screening newborns through whole genome sequencing.
Sema4|GeneDx has announced their position in the Genomic Uniform-screening Against Rare Diseases In All Newborns (GUARDIAN) study, a genome sequencing program for newborns.
By using whole genome sequencing (WGS), GUARDIAN is able to screen 100,000 newborns for health conditions that would not be found in normal newborn screenings. This can improve infants’ quality of health through early diagnosis and treatment, eventually expanding newborn screening through genomic sequencing.
Risk of death and disability is decreased through newborn screening, which can detect conditions that might lead to long-term consequences. Criteria were chosen for GUARDIAN screening, including: median age of onset before 5 years of age, greater than 90% probability of the condition developing based on the genetic result, effective treatments, and a well-established natural history of the condition.
Sema4|GeneDX will be applying their industry leading curated dataset to WGS, as they will be able to provide more answers to patients and serve as a basis for information and reporting. Currently, over 180 hospitals in the United States are using rapid exome and genome offerings from Sema4|GeneDX.
All babies born in New York City as part of the GUARDIAN partner health system will be eligible to participate in the study. Sema4|GeneDX hopes that this study will lead to characterization of prevalence and natural history of rare genetic conditions.
Reference
Moss R. Sema4|GeneDx to provide whole genome sequencing and interpretation services for landmark genomic newborn screening study. Sema4. Accessed October 7, 2022. https://ir.sema4.com/news-releases/news-release-details/sema4genedx-provide-whole-genome-sequencing-and-interpretation
Prevention strategies are key to child safety this summer
As children get set to head into the sun, grass, and water, now is the perfect time to remind patients and parents about best practices, treatments, and preventive measures.
Food Insecurity and the Dangers of Infant Formula Dilution
New skin patch tested for peanut immunotherapy in toddlers
A new study investigates taking this treatment a step further, evaluating the effect of epicutaneous immunotherapy in toddlers with known peanut allergies.
Demystifying Infant Formula
Increases of anxiety disorder diagnoses met with declining treatment visits
An increase in outpatient visits that included an anxiety diagnosis was also met with a decrease in treatment visits, while there was no significant change in the overall use of medications in all time periods.
How children transmitted COVID-19 within households
Following household COVID-19 transmissions for over 3 years, investigators found that 70.4% had a pediatric index case.
2 Clarke Drive
Cranbury, NJ 08512
609-716-7777
source
At SeeVay, we know that the safety and well-being of your baby is your top priority. That’s why we’re dedicated to providing you with the tools you need to make sure you’re always on top of your baby’s safety. We understand that being a new mom can be overwhelming, and there’s so much information out there that it can be hard to know where to start.
